|
| Status |
Public on Dec 18, 2012 |
| Title |
UPN 410324, 3 day DAC treatment, array plate number 7 |
| Sample type |
genomic |
| |
|
| Source name |
Bone marrow biopsy, DAC
|
| Organism |
Homo sapiens |
| Characteristics |
disease status: acute myeloid leukemia (AML)
fab: M5
molecular classification: MLL translocation, poor risk
gender: male
age: 60 years
tissue: bone marrow
treatment: decitabine (DAC)
aml sample identifier: 410324
array plate number: 7
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Genomic DNA was extracted and purified using the Qiagen QIAamp DNA Mini Kit according to standard instructions.
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina protocol.
|
| |
|
| Hybridization protocol |
Bisulfite-converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 BeadChips using the standard Illumina protocol.
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using the standard recommended Illumina scanner setting.
|
| Description |
410324_DAC_7
|
| Data processing |
BeadStudio software v3.2.
|
| |
|
| Submission date |
Sep 13, 2012 |
| Last update date |
Dec 18, 2012 |
| Contact name |
Nobish Varghese |
| E-mail(s) |
nvarghese@path.wustl.edu
|
| Organization name |
Washington University in St.Louis
|
| Street address |
4444 Forest Park Ave.
|
| City |
StLouis |
| State/province |
MO |
| ZIP/Postal code |
63110 |
| Country |
USA |
| |
|
| Platform ID |
GPL13534 |
| Series (2) |
| GSE40870 |
Transient low-dose decitabine treatment of primary AML samples |
| GSE40871 |
Gene expression and methylation profiling in primary AML cells treated with decitabine and cytarabine |
|
